Fresenius Medical Care AG & Co. (ADR)  

(Public, NYSE:FMS)   Watch this stock  
Find more results for FMS
38.68
+0.31 (0.81%)
Dec 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 38.42 - 38.94
52 week 38.05 - 47.52
Open 38.47
Vol / Avg. 133,043.00/187,664.00
Mkt cap 23.35B
P/E 20.17
Div/yield 0.45/1.17
EPS 1.92
Shares 306.14M
Beta 0.52
Inst. own 5%

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 8.82% 7.85%
Operating margin 14.57% 13.90%
EBITD margin - 17.63%
Return on average assets 6.12% 5.17%
Return on average equity 12.87% 10.65%
Employees 109,000 -
CDP Score - 92 C

Address

Else-Kroener-Strasse 1
BAD HOMBURG, 61352
Germany
+49-6172-6090 (Phone)
+49-6172-6092301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Fresenius Medical Care AG & Co. KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America. The Company develops and manufactures a range of dialysis machines, systems and disposable products. The Company's dialysis business provides dialysis treatment at its own dialysis clinics and supplies the clinics with a range of products. In addition, it sells dialysis products to other dialysis service providers. The Company's Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, and health plan services and urgent care services.

Officers and directors

Gerd Krick Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Rice Powell Chairman of the Management Board, Chief Executive Officer
Bio & Compensation  - Reuters
Dieter Schenk Vice Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Michael Brosnan Chief Financial Officer, Member of the Management Board
Bio & Compensation  - Reuters
Oliver Maier Senior Vice President of Investor Relations
Bio & Compensation  - Reuters
Harry De Wit Member of the Management Board, Chief Executive Officer for Asia-Pacific
Age: 53
Bio & Compensation  - Reuters
Ronald Kuerbitz Member of the Management Board, Chief Executive Officer for North America
Bio & Compensation  - Reuters
Olaf Schermeier Member of the Management Board for Global Research & Development
Bio & Compensation  - Reuters
Kent Wanzek Member of the Management Board, Global Products Manufacturing Operations
Bio & Compensation  - Reuters
Dominik Wehner Member of the Management Board for Europe, Middle East and Africa and Labour Relations Director
Bio & Compensation  - Reuters